Items Tagged ‘#liquid biopsies’

October 11th, 2017

#CIMCon17 – precision medicine for smoking cessation, rare diseases and cancer screening

By Sharon Rosen sharonhrosen

Ever wonder why some people can quit smoking while others try repeatedly without success?  The answer may be related to your genetic makeup. Studies have shown that 70 percent of smokers want to quit, but only three percent are successful each year. That’s according to Rachel Tyndale, Ph.D., professor of Pharmacology and Psychiatry, Centre for […]

View full entry

Tags: #cell-free DNA testing, #Dr. Minetta Liu, #Dr. Muhammed Murtaza, #Dr. Rachel Tyndale, #Dr. Richard Williams, #Dr. William Gahl, #liquid biopsies, #pharmacogenomics testing, #rare diseases, #rare genetic disorders, #smoking cessation, #Undiagnosed Disease Network


October 10th, 2017

#CIMCon 17 is underway

By Sharon Rosen sharonhrosen

“Genomic medicine is already part of mainstream medical care,” says  A. Keith Stewart, M.B., Ch.B., in his opening remarks at the sixth Individualizing Medicine 2017: Advancing Care Through Genomics, a conference hosted by the Mayo Clinic Center for Individualized Medicine. Dr. Stewart, the Carlson and Nelson director of the Center for Individualized Medicine, kicked off the conference yesterday […]

View full entry

Tags: #cell-free DNA testing, #CIMCon17, #Dr. David Ledbetter, #Geisinger Health System, #genomic testing, #Individualizing Medicine Conference 2017, #liquid biopsies, #MyCode Community Health Initiative, #rare diseases, cancer, center for individualized medicine, Dr. Keith Stewart


October 3rd, 2017

Liquid biopsies: detecting and treating cancer sooner

By Sharon Rosen sharonhrosen

What if a blood test could discover cancer before a tumor first appears or before the first signs of cancer recurrence are seen by a radiology study? In fact, these types of blood tests, often called liquid biopsies, are already changing clinical care for patients with cancer. Researchers and physicians in Mayo Clinic Center for […]

View full entry

Tags: #blood tests, #cancer treatment, #cell-free DNA testing, #CIMCon17, #circulating tumor cells, #Dr. Minetta Liu, #Individualizing Medicine 2017, #liquid biopsies, Advanced Cancer, breast cancer, cancer, cancer screening


August 2nd, 2017

Expanding the search: genetic testing reveals new targets, treatment options for cancer patients

By Sharon Rosen sharonhrosen

Researchers in Mayo Clinic Center for Individualized Medicine are using new genetic tests developed at Mayo Clinic to find more effective therapies for cancer patients who have not benefited from standard treatment and are running out of options. The new tests look at a broader range of genetic characteristics than many standard tests. As a […]

View full entry

Tags: #3-d models, #boimarker, #CIMCon17, #DNA analysis, #Dr. Aaron Mansfield, #Dr. George Vasmatizis, #genetic variations, #liquid biopsies, center for individualized medicine, Genetic Testing, genomics, Lung Cancer


October 11th, 2016

New biomarker discovery approaches to improve patient care

By susanbuckles susanbuckles

Biomarkers are an important measure of health and disease that can help doctors understand how to more effectively treat cancerous tumors. The topic of TIGER-Bio, a new approach to biomarker discovery, came into the spotlight in a workshop on the final morning of Individualizing Medicine 2016: Advancing Care through Genomics, The session, TIGER-Bio: The Integrated […]

View full entry

Tags: #3-D genomic models, #bomarker discovery, #Dr. Mark Truty, #Dr. Minetta Liu, #Dr. Mitesh Borad, #liquid biopsies, #xenograph models, Cancer Research, center for individualized medicine, DNA Sequencing, Dr. George Vasmatzis, Genomic Research


Contact Us · Privacy Policy